BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 25853911)

  • 21. GAB(A) receptors present higher affinity and modified subunit composition in spinal motor neurons from a genetic model of amyotrophic lateral sclerosis.
    Carunchio I; Mollinari C; Pieri M; Merlo D; Zona C
    Eur J Neurosci; 2008 Oct; 28(7):1275-85. PubMed ID: 18973555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calpastatin inhibits motor neuron death and increases survival of hSOD1(G93A) mice.
    Rao MV; Campbell J; Palaniappan A; Kumar A; Nixon RA
    J Neurochem; 2016 Apr; 137(2):253-65. PubMed ID: 26756888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered macroautophagy in the spinal cord of SOD1 mutant mice.
    Li L; Zhang X; Le W
    Autophagy; 2008 Apr; 4(3):290-3. PubMed ID: 18196963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis.
    Kim J; Kim TY; Cho KS; Kim HN; Koh JY
    Neurobiol Dis; 2013 Nov; 59():80-5. PubMed ID: 23891729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.
    Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C
    Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
    Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
    Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice.
    Butovsky O; Jedrychowski MP; Cialic R; Krasemann S; Murugaiyan G; Fanek Z; Greco DJ; Wu PM; Doykan CE; Kiner O; Lawson RJ; Frosch MP; Pochet N; Fatimy RE; Krichevsky AM; Gygi SP; Lassmann H; Berry J; Cudkowicz ME; Weiner HL
    Ann Neurol; 2015 Jan; 77(1):75-99. PubMed ID: 25381879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS.
    Garbuzova-Davis S; Haller E; Saporta S; Kolomey I; Nicosia SV; Sanberg PR
    Brain Res; 2007 Jul; 1157():126-37. PubMed ID: 17512910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of thymic stimulation of CD4+ T cell expansion on disease onset and progression in mutant SOD1 mice.
    Sheean RK; Weston RH; Perera ND; D'Amico A; Nutt SL; Turner BJ
    J Neuroinflammation; 2015 Feb; 12():40. PubMed ID: 25889790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Bryson JB; Hobbs C; Parsons MJ; Bosch KD; Pandraud A; Walsh FS; Doherty P; Greensmith L
    Hum Mol Genet; 2012 Sep; 21(17):3871-82. PubMed ID: 22678056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered expression of DJ-1 and PINK1 in sporadic ALS and in the SOD1(G93A) ALS mouse model.
    Knippenberg S; Sipos J; Thau-Habermann N; Körner S; Rath KJ; Dengler R; Petri S
    J Neuropathol Exp Neurol; 2013 Nov; 72(11):1052-61. PubMed ID: 24128678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
    Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
    J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Focal dysfunction of the proteasome: a pathogenic factor in a mouse model of amyotrophic lateral sclerosis.
    Kabashi E; Agar JN; Taylor DM; Minotti S; Durham HD
    J Neurochem; 2004 Jun; 89(6):1325-35. PubMed ID: 15189335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An astrocyte regenerative response from vimentin-containing cells in the spinal cord of amyotrophic lateral sclerosis's disease-like transgenic (G93A SOD1) mice.
    Zhou Y; Lu Y; Fang X; Zhang J; Li J; Li S; Deng X; Yu Y; Xu R
    Neurodegener Dis; 2015; 15(1):1-12. PubMed ID: 25591625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased glutathione accelerates neurological deficit and mitochondrial pathology in familial ALS-linked hSOD1(G93A) mice model.
    Vargas MR; Johnson DA; Johnson JA
    Neurobiol Dis; 2011 Sep; 43(3):543-51. PubMed ID: 21600285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
    Tokuda E; Okawa E; Watanabe S; Ono S
    Hum Mol Genet; 2014 Mar; 23(5):1271-85. PubMed ID: 24163136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis.
    Beqollari D; Romberg CF; Dobrowolny G; Martini M; Voss AA; Musarò A; Bannister RA
    Skelet Muscle; 2016; 6():24. PubMed ID: 27340545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modeling amyotrophic lateral sclerosis in hSOD1 transgenic swine.
    Chieppa MN; Perota A; Corona C; Grindatto A; Lagutina I; Vallino Costassa E; Lazzari G; Colleoni S; Duchi R; Lucchini F; Caramelli M; Bendotti C; Galli C; Casalone C
    Neurodegener Dis; 2014; 13(4):246-54. PubMed ID: 24157939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis.
    Hensley K; Floyd RA; Gordon B; Mou S; Pye QN; Stewart C; West M; Williamson K
    J Neurochem; 2002 Jul; 82(2):365-74. PubMed ID: 12124437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels.
    Bendotti C; Tortarolo M; Suchak SK; Calvaresi N; Carvelli L; Bastone A; Rizzi M; Rattray M; Mennini T
    J Neurochem; 2001 Nov; 79(4):737-46. PubMed ID: 11723166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.